Press release
Cell-based Assay Market worth $35.65 billion by 2030, growing at a CAGR of 8.11% - Exclusive Report by 360iResearch
The "Cell-based Assay Market by Offerings (Consumables, Instruments, Services), Application (Basic Research, Drug Discovery), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Cell-based Assay Market to grow from USD 20.64 billion in 2023 to USD 35.65 billion by 2030, at a CAGR of 8.11%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Cell-based assays are laboratory analytical techniques that utilize living cells to evaluate the biochemical or physiological effects of chemical compounds in a biologically relevant context. These assays are integral to drug discovery, cytotoxicity testing, and various biological research areas. They offer insights into cellular responses to external stimuli, including drug efficiency and toxicity, allowing for a more accurate prediction of how these compounds will behave in living organisms. The increasing global focus on drug discovery and development, especially for chronic diseases and cancer, heavily relies on cell-based assays for initial screening, thereby propelling the need for cell-based assays. Higher investment in research and development activities by pharmaceutical companies and government bodies globally supports the expansion of the cell-based assay market. However, the operational complexity and the need for specialized skills to perform assays can limit their adoption, especially in resource-constrained settings. Furthermore, variabilities in cell lines and assay conditions across different laboratories can lead to inconsistent results, complicating data interpretation. However, key players are exploring the integration of three-dimensional (3D) cell culture methods to offer a more physiologically relevant environment for cell-based assays, potentially improving the predictive accuracy of drug responses. Applying AI and machine learning for data analysis in cell-based assays could enhance the efficiency, accuracy, and predictive power of assays, creating new pathways in drug discovery and biological research.
The Americas region, particularly the U.S. and Canada, features a robust landscape for cell-based assay, owing to the presence of a highly developed healthcare infrastructure and several pharmaceutical and research organizations. The United States leads the cell-based assay market in the Americas due to significant healthcare spending and a strong regulatory framework favoring the approval of cell-based assays. Recent patents reveal innovations in high-throughput screening and 3D cell culture techniques. In the EU, the cell-based assay market is growing due to supportive government initiatives, a strong focus on R&D, and increasing collaborations between academic institutions and pharmaceutical companies. The demand is mainly for innovative, time-efficient, and cost-effective assay systems. Recent EU funding programs are aimed at accelerating the development of novel assays and personalized medicine solutions. The presence of stringent regulations for medical, pharmaceutical, and research products in the EU region creates a standardized framework for the progress of cell-based assays. The Middle East and Africa market is emerging, with growth driven by investments in healthcare infrastructure and an increasing number of research partnerships. APAC's cell-based assay market is rapidly growing, fueled by government funding for biotech and healthcare R&D, along with surging demand for personalized medicine. Chinese researchers are at the forefront of developing innovative cell-based assays, including novel biosensors and microfluidic devices, reflecting the country's commitment to leading in this sector. Japan is a pioneer in regenerative medicine and tissue engineering, areas that extensively use cell-based assays. India's cell-based assay market is experiencing substantial growth, driven by expanding biotech and pharmaceutical sectors, as well as increased government and foreign investments in healthcare research.
Market Segmentation & Coverage:
This research report categorizes the Cell-based Assay Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents. The Services is projected to witness significant market share during forecast period.
Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies. The Drug Discovery is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.10% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Cell-based Assay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Cell-based Assay Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Cell-based Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canvax Reagents S.L., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Corning Inc., Danaher Corporation, Elabscience Bionovation Inc., Enzo Life Sciences, Inc.,, Eurofins Scientific SE, GE HealthCare Technologies Inc., InSphero AG, Intertek Group plc, InvivoGen, Lonza Group Ltd., Merck KGaA, Molecular Devices, LLC., Perkinelmer, Inc., Promega Corporation, ReadyCell, S.L., Sartorius AG, and Thermo Fisher Scientific Inc..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Cell-based Assay Market, by Offerings
7. Cell-based Assay Market, by Application
8. Cell-based Assay Market, by End-User
9. Americas Cell-based Assay Market
10. Asia-Pacific Cell-based Assay Market
11. Europe, Middle East & Africa Cell-based Assay Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Cell-based Assay Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Cell-based Assay Market?
3. What is the competitive strategic window for opportunities in the Cell-based Assay Market?
4. What are the technology trends and regulatory frameworks in the Cell-based Assay Market?
5. What is the market share of the leading vendors in the Cell-based Assay Market?
6. What modes and strategic moves are considered suitable for entering the Cell-based Assay Market?
Read More @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
The Global Cell-based Assay Market to grow from USD 20.64 billion in 2023 to USD 35.65 billion by 2030, at a CAGR of 8.11%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Cell-based assays are laboratory analytical techniques that utilize living cells to evaluate the biochemical or physiological effects of chemical compounds in a biologically relevant context. These assays are integral to drug discovery, cytotoxicity testing, and various biological research areas. They offer insights into cellular responses to external stimuli, including drug efficiency and toxicity, allowing for a more accurate prediction of how these compounds will behave in living organisms. The increasing global focus on drug discovery and development, especially for chronic diseases and cancer, heavily relies on cell-based assays for initial screening, thereby propelling the need for cell-based assays. Higher investment in research and development activities by pharmaceutical companies and government bodies globally supports the expansion of the cell-based assay market. However, the operational complexity and the need for specialized skills to perform assays can limit their adoption, especially in resource-constrained settings. Furthermore, variabilities in cell lines and assay conditions across different laboratories can lead to inconsistent results, complicating data interpretation. However, key players are exploring the integration of three-dimensional (3D) cell culture methods to offer a more physiologically relevant environment for cell-based assays, potentially improving the predictive accuracy of drug responses. Applying AI and machine learning for data analysis in cell-based assays could enhance the efficiency, accuracy, and predictive power of assays, creating new pathways in drug discovery and biological research.
The Americas region, particularly the U.S. and Canada, features a robust landscape for cell-based assay, owing to the presence of a highly developed healthcare infrastructure and several pharmaceutical and research organizations. The United States leads the cell-based assay market in the Americas due to significant healthcare spending and a strong regulatory framework favoring the approval of cell-based assays. Recent patents reveal innovations in high-throughput screening and 3D cell culture techniques. In the EU, the cell-based assay market is growing due to supportive government initiatives, a strong focus on R&D, and increasing collaborations between academic institutions and pharmaceutical companies. The demand is mainly for innovative, time-efficient, and cost-effective assay systems. Recent EU funding programs are aimed at accelerating the development of novel assays and personalized medicine solutions. The presence of stringent regulations for medical, pharmaceutical, and research products in the EU region creates a standardized framework for the progress of cell-based assays. The Middle East and Africa market is emerging, with growth driven by investments in healthcare infrastructure and an increasing number of research partnerships. APAC's cell-based assay market is rapidly growing, fueled by government funding for biotech and healthcare R&D, along with surging demand for personalized medicine. Chinese researchers are at the forefront of developing innovative cell-based assays, including novel biosensors and microfluidic devices, reflecting the country's commitment to leading in this sector. Japan is a pioneer in regenerative medicine and tissue engineering, areas that extensively use cell-based assays. India's cell-based assay market is experiencing substantial growth, driven by expanding biotech and pharmaceutical sectors, as well as increased government and foreign investments in healthcare research.
Market Segmentation & Coverage:
This research report categorizes the Cell-based Assay Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents. The Services is projected to witness significant market share during forecast period.
Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies. The Drug Discovery is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.10% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Cell-based Assay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Cell-based Assay Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Cell-based Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canvax Reagents S.L., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Corning Inc., Danaher Corporation, Elabscience Bionovation Inc., Enzo Life Sciences, Inc.,, Eurofins Scientific SE, GE HealthCare Technologies Inc., InSphero AG, Intertek Group plc, InvivoGen, Lonza Group Ltd., Merck KGaA, Molecular Devices, LLC., Perkinelmer, Inc., Promega Corporation, ReadyCell, S.L., Sartorius AG, and Thermo Fisher Scientific Inc..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Cell-based Assay Market, by Offerings
7. Cell-based Assay Market, by Application
8. Cell-based Assay Market, by End-User
9. Americas Cell-based Assay Market
10. Asia-Pacific Cell-based Assay Market
11. Europe, Middle East & Africa Cell-based Assay Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Cell-based Assay Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Cell-based Assay Market?
3. What is the competitive strategic window for opportunities in the Cell-based Assay Market?
4. What are the technology trends and regulatory frameworks in the Cell-based Assay Market?
5. What is the market share of the leading vendors in the Cell-based Assay Market?
6. What modes and strategic moves are considered suitable for entering the Cell-based Assay Market?
Read More @ https://www.360iresearch.com/library/intelligence/cell-based-assay?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
